Skip to content
Open Data Finder
Open Government Canada

Notice: Prescription Drug List (PDL): Multiple Additions (2021-10-21)

Published by Health Canada | Santé Canada

About this dataset

The purpose of this Notice of Amendment is to notify of the addition of the following medicinal ingredients on the Prescription Drug List (PDL) for human and veterinary use: Infigratinib or its salts, Lurbinectedin or its salts or derivatives, Pemigatinib or its salts, Propylthiouracil or its salts, Sacituzumab govitecan, and Sotorasib.

Notice: Prescription Drug List (PDL): Multiple Additions (2021-10-21) · Open Data Finder